|
Volumn 49, Issue SUPPL.6, 2008, Pages 1-
|
Central nervous system infections and epilepsy
a b b |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICONVULSIVE AGENT;
ANTIINFECTIVE AGENT;
ANTICONVULSANT THERAPY;
ANTIMICROBIAL THERAPY;
ATTRIBUTABLE RISK;
BACTERIAL MENINGITIS;
BRAIN CYSTICERCOSIS;
BRAIN MALARIA;
CENTRAL NERVOUS SYSTEM INFECTION;
CONGENITAL HYPOTHYROIDISM;
DISEASE ASSOCIATION;
EDITORIAL;
EPIDEMIC;
EPIDEMIC ENCEPHALITIS;
EPILEPSY;
HELMINTHIASIS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INCIDENCE;
PLASMODIUM FALCIPARUM;
PRIORITY JOURNAL;
TOXOCARIASIS;
TREATMENT OUTCOME;
VIRUS ENCEPHALITIS;
ANIMALS;
ANTI-BACTERIAL AGENTS;
ANTICONVULSANTS;
BRAIN;
CENTRAL NERVOUS SYSTEM BACTERIAL INFECTIONS;
EPILEPSY;
HUMANS;
PLASMODIUM FALCIPARUM;
TAENIA SOLIUM;
|
EID: 50249136097
PISSN: 00139580
EISSN: 15281167
Source Type: Journal
DOI: 10.1111/j.1528-1167.2008.01748.x Document Type: Editorial |
Times cited : (16)
|
References (0)
|